Technology brings university scientists unparalleled potential for chemical, biological and human disease research
Designed for quantitative analysis, Waters' full portfolio of TQ MS systems make high performance and routine analysis accessible, robust, reliable
As the number of analytical monitoring tests for biopharmaceuticals skyrockets, Waters builds intelligence into a fit-for-purpose system
Kairos Amino Acid Analysis Kit simplifies and automates LC/MS-MS wuantification of amino acids in human plasma and urine
New sample preparation workflow produces exceptionally clean samples for robust and accurate LC and LC-MS quantification
Biopharmaceutical laboratories can now take advantage of the power of the ACQUITY Arc™ platform for creating robust and reliable methods that can be transferred easily
In addition to getting performance-driven columns, users of BioResolve brand columns will receive application-focused standards, templated methods, and an enhanced level of applications support
Problem: The topic of technology transfer raises caution with many laboratory managers of analytical laboratories. In routine analysis laboratories, such as QA/QC, the need for continued support of established high performance liquid chromatography (HPLC) methods can significantly outweigh the potential advantages of method modernization, making it exceptionally problematic or undesirable to adopt more modern liquid chromatography (LC) assays or instrumentation such as U(H)PLC ultra-high performance LC.
Agilent Technologies Inc. (NYSE: A) and Waters Corp. (NYSE: WAT) announced a formal agreement on June 11 to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.